Anubis Barcelona Concentrate
NDC Package 83021-546-30

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Anubis Barcelona (dmae) concentrates is classified as a

administered via topical route. This formulation utilizes a concentrate delivery system. Marketed by Anubis Cosmetics Sl, this product is identified by NDC 83021-546 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
83021-546-30
Package Description
30 mL in 1 BOTTLE, DROPPER
Product Code
83021-546
11-Digit Billing Format
83021054630

Clinical Specifications

Proprietary Name
Anubis Barcelona
Non-Proprietary Name
Dmae
Substance Name
Ascorbyl Glucoside; Benzoic Acid; Dehydroacetic Acid; Dicaprylyl Ether; Fragrance 13576; Glycerin; Hydrolyzed Bovine Elastin (base; 1000 Mw); Hydroxycitronellal; Hydroxyethyl Acrylate/sodium Acryloyldimethyl Taurate Copolymer (100000 Mpa.s At 1.5%); Lecithin, Soybean; Limonene, (+)-; Phenoxyethanol; Polysorbate 60; Propanediol; Sorbitan Isostearate; Tocopherol; Water; Xanthan Gum
Dosage Form
Concentrate - A liquid preparation of increased strength and reduced volume which is usually diluted prior to administration.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class

Regulatory & Marketing

Labeler Name
Anubis Cosmetics Sl
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
01-13-2023
End Marketing Date
08-05-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83021-546-30 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Anubis Barcelona, a human over the counter drug labeled by Anubis Cosmetics Sl. This concentrate is formulated for topical use and contains ascorbyl glucoside; benzoic acid; dehydroacetic acid; dicaprylyl ether; fragrance 13576; glycerin; hydrolyzed bovine elastin (base; 1000 mw); hydroxycitronellal; hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer (100000 mpa.s at 1.5%); lecithin, soybean; limonene, (+)-; phenoxyethanol; polysorbate 60; propanediol; sorbitan isostearate; tocopherol; water; xanthan gum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Anubis Cosmetics Sl on January 13, 2023.

How is this Anubis Cosmetics Sl product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83021054630. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83021-546-30
11-Digit CMS (5-4-2)
83021-0546-30

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.